KARAKAŞ, Z. Et Al. 2020. WHAT SHOULD BE THE FIRST TREATMENT OPTION IN A PATIENT WITH CML DIAGNOSED WITHMYELOFIBROSIS AT THE TIME OF DIAGNOSIS?. EHA .

KARAKAŞ, Z., BİLİCİ, M., TUNA, R., ŞAHİN, Ş., IŞIK, S., KARAMAN, S., ... TUĞCU, D.(2020). WHAT SHOULD BE THE FIRST TREATMENT OPTION IN A PATIENT WITH CML DIAGNOSED WITHMYELOFIBROSIS AT THE TIME OF DIAGNOSIS? . EHA

KARAKAŞ, Zeynep Et Al. "WHAT SHOULD BE THE FIRST TREATMENT OPTION IN A PATIENT WITH CML DIAGNOSED WITHMYELOFIBROSIS AT THE TIME OF DIAGNOSIS?," EHA, 2020

KARAKAŞ, Zeynep Et Al. "WHAT SHOULD BE THE FIRST TREATMENT OPTION IN A PATIENT WITH CML DIAGNOSED WITHMYELOFIBROSIS AT THE TIME OF DIAGNOSIS?." EHA , 2020

KARAKAŞ, Z. Et Al. (2020) . "WHAT SHOULD BE THE FIRST TREATMENT OPTION IN A PATIENT WITH CML DIAGNOSED WITHMYELOFIBROSIS AT THE TIME OF DIAGNOSIS?." EHA .

@conferencepaper{conferencepaper, author={Zeynep KARAKAŞ Et Al. }, title={WHAT SHOULD BE THE FIRST TREATMENT OPTION IN A PATIENT WITH CML DIAGNOSED WITHMYELOFIBROSIS AT THE TIME OF DIAGNOSIS?}, congress name={EHA}, city={}, country={}, year={2020}}